Author Archives: donttradeourlivesaway

Why The Request By Least Developed Countries For An Extension Of The Transitional Period For Granting And Enforcing Medicines Patents Needs To Be Supported

Source: IP Watch 27th February 2015 On 24 February 2015 Bangladesh on behalf of the 34 Least Developed Country members (LDCs) of the World Trade Organization (WTO) submitted a request for an extension of the transitional period under article 66.1 … Continue reading

Posted in LDC Extension, LDCs, TRIPS, TRIPS flexibilities | Leave a comment

WTO: LDC request for extension of transition period on pharmaceuticals

Source: Third World Network New Delhi, 25 February (K. M. Gopakumar) – Least developed countries have submitted a request for the extension of the transition period with regard to intellectual property protection of pharmaceutical products. The request seeks an extension … Continue reading

Posted in LDC Extension, LDCs, TRIPS, TRIPS flexibilities | Leave a comment

WTO TRIPS Council : LDC request for extension of the transitional period for pharmaceutical products

Source: Knowledge Ecology International 24th February 2015 The World Trade Organization (WTO) is convening the TRIPS Council from Tuesday, 24 February 2015 to Wednesday, 25 February 2015. As mentioned in a previous piece, Norway and the United States “have submitted … Continue reading

Posted in LDC Extension, LDCs, TRIPS, TRIPS flexibilities | Leave a comment

Gilead looks overseas to guard Sovaldi profits from taxes

Source: Fierce Pharma 4 Mar 2015 Tax inversion deals are not the only trick Big Pharma has up its sleeve to avoid steep U.S. tax rates. Gilead Sciences ($GILD) is booking profits overseas in low-tax countries to take home more … Continue reading

Posted in Hepatitis - C, patent | Leave a comment

Entry of worthless patents under proposed IPR regime?

Source: Deccan Herald 4 Mar 2015 The draft National Intellectual Property Rights Policy developed by an IPR think tank set up by the Union government has been put on the website of Department of Industrial Policy and Promotion for public … Continue reading

Posted in Indian Patent Law, IP Think Tank, IPR policy, Utility Model | Leave a comment

Trade Group Wants to See Stricter Limits on Compulsory Licensing

Source: RAPS 4 Mar 2015 A US-based trade group wants to see the United States Trade Representative (USTR) pursue stricter limits on the ability of countries to bypass patent protection. In its Special 301 Submission 2015, the Pharmaceutical Research and … Continue reading

Posted in Compulsory Licensing, Special 301 report, US pressure on India | Leave a comment

LDC Members’ Entitlement to and Need for a Further Extension of Their Pharmaceutical Transition Period

Source: Info Justice 4 Mar 2015 LDCs Members have submitted a duly motivated request for an unconditional extension of the 2002-2016 pharmaceutical transition period (covering patents and data) and for relief from the requirements of TRIPS Article 70.8 and 70.9 … Continue reading

Posted in LDC Extension, LDCs, TRIPS plus | Leave a comment